Dr. Ferrari is a noted leader in biomedical nanotechnology research and has served as “special expert on nanotechnology” at The National Cancer Institute in Bethesda, Md., where he led the development of the NCI’s program in nanotechnology.
His scientific interests include cancer, traumatic injury, cardiovascular medicine and infectious disease. Dr. Ferrari holds a Ph.D in mechanical engineering from the University of California at Berkeley and a doctorate in mathematics from Universita’ di Padova in Italy.
Dr. Ferrari also serves as president of the Alliance for NanoHealth and professor of experimental therapeutics at the University of Texas M.D. Anderson Cancer Center in Houston.
Read the Newswise article on Mauro Ferrari.
Read more on recent executive moves:
–Ripon Medical Center Names Interim CEO
–Provena Saint Joseph Hospital Names President and CEO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
